Menopause Flashcards

(60 cards)

1
Q

Reproductive aging

A

Process begins in embryonic life
20 weeks gestation – 6 to 7 million follicles
At birth – 1.5 to 2 million follicles
At menarche – 300,000 to 400,000 follicles
Follicular atresia continues throughout life.
Follicular loss accelerates when the total number of follicles is about *25,000.
When follicles are sufficiently depleted **
(<1000), menopause occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

menopausal changes

A

Rise in triglycerides, decrease HDL, Increase LDL, lipid metabolism decreases
Plaque development
Atrophy I vagina- loss of support, sexual dysfunction, dryness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Perimenopause

A
This marks the period “around menopause”
Declining fertility
Transition towards menopause
Usually in the 40’s
Estrogen levels rise/fall – “unstable” 
Biggest complaint is menstrual irregularities*****
Duration 2-8 years (average 5 yrs.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Presenting symptoms

A
Irregular periods, DUB, Menorrhagia - Prolonged and excessive uterine bleeding occurring at regular intervals  
Menopausal symptoms
PMS symptoms
Vaginal dryness
Urinary incontinence
Mood swings
Sexual dysfunction
Decreased fertility
(Cramping, vaginal drynss, acne, pelvic floor not holding well, incontinence)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk Factors

A
Family history – research shows no link
Undergo menopause at a younger age
Smokers
Type 1 DM
Increased altitude
Autoimmune syndromes
Undernourished/vegetarians
Cancer treatment- induces menopause
Hysterectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Managing Perimenopause

A
Goals:
Patient education
Prevention of endometrial cancer*******
Individualized symptomatic relief
Menstrual control
Minimizing hot flashes
Mood disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment begins with Education

A

Should begin at age 40 at yearly visits
Vaginal dryness: Replens, Astroglide, KY jelly, lubrin, Vit E 100-600/day, evening primrose oil 2-4 capsule/day
Diet, Exercise for prevention of osteoporosis, Calcium 1000-1500mg/day with 400-800mg/day of Vit D.
SBE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment begins with Education

A

Yearly mammogram and pelvic examination
need for contraception until 1 year of no menses
s/s of post menopausal bleeding and risks
Vaginal atrophy, sexual dysfunction
kiegles exercises - prolapse
(Educate, emphasize if any abnormal bleeding after menopause is a bad sign)
(Endometrial biopsy- r/o endometriosis
stabilize lining of the uterus
Antidepressant can help with hot flashes as well)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment options

A

Treatment should be catered towards presenting symptoms
Bleeding – after confirming bleeding is benign and from hormonal instability, COC, POP, LNG-IUD- marina, cycling progesterone, cryoablation- hormonal changes
Vaginal atrophy – OTC lubricants, vaginal estrogen RX
Mood irritability – antidepressants – SSRI-fluoxetine, Effexor- anxiety, depression
Menopausal symptoms – often relieved if you can stabilize hormones. COC a good option. Gabapentin (neurontin) reduced HF/NS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment notes

A

Biopsy done first to evaluate abnormal bleeding,
TVS- transvaginal study, US
FSH and LH- not going to look at the
CBC- rule out anemia, TSH, r/o thyroid problems, then US checking, FSH and LH is going to be normal that the hormones are being produces,
Menopausal s
6 mos no period- FSH, estradiol
Greater tba 40, extramenopausal- transioning, don’t do a test, unless you will get result that
6 wks after hysterectomy will be induced into menopause
If hysterectomy, but ovaries intact- if hot flashes then you can check FSH and estradiol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Menopause definition**

A

Marks the end of reproductive life
Cessation of menses for greater than 1 year**
Surgical removal of the ovaries- abrupt menopausal state
s/p hyst with ovarian preservation and estradiol production has decreased to the menopausal level
Average age in the US – 51yrs
Premature < 40 (1%)
Early Menopause 55 (5%)
** Premature and early - higher risk of osteoporosis and CVD
***

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A 50 year old perimenopausal patient presents with irregular bleeding at intervals of 20 to 24 days lasting 5-6 days and at times heavy over the past 6 months. Her pelvic exam is wnl. Appropriate management would include:
A. LNG-IUD
B. Continuous estrogen-progesterone therapy
C. COC
D. Endometrial biopsy or ultrasound

A

D

heavier, clottier bld

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A 45 yr old female patient presents with a 6-month history of heavy, irregular periods every 24-30 days and lasting 8-10days. She is not currently bleeding.  Pelvic exam reveals a normal sized, non-tender uterus and normal adnexa.  Which one of the following tests would not be appropriate in the initial evaluation of this problem?
A.  CBC
B.  FSH and LH
C.  TSH
D.  TVS (transvaginal ultrasound)
A

B
PERIMENOPAUSE LABS
(hormonal studies will show she is bleeding (FSH, LH normal), CBC to r/o anemia, TSH check thyroid, ultrasound will show pathology)
Hormonal studies- if perimenopausal fsh creeping up,
at 6 mos after no bleeding check FSH, estradiol
greater than 40 FSH- menopausal (if only high FSH, then getting there)
less than 35 estradiol- menopausal)
if had hysterectomy- 6 weeks and she will be in menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
Which of the following is NOT considered to be a possible factor in earlier age of menopause?
A.  Autoimmune syndromes
B.  Current smoking
C.  Multiparity
D.  Type 1 DM
A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Etiology

A

Physiologic: Results from changes in the ovary, with gradual atresia of ovarian follicles leading to a decrease in ovarian production of Estrogen & Progesterone. Fewer available follicles to produce Estradiol –most potent E2, circulating estrongen*
Estrone becomes the primary E2 which is derived from conversion of androstenedisone to estrone in extraglandular sites

(During this transition, variations in FSH and estradiol levels, therefore these lab values are not reliable guides to a womans menopausal status)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Long term Impacts of Estrogen Decline

A

Vaginal – dryness, atrophy
Brain – forgetfulness, poor concentration
Bone – Osteoporosis
Blood vessels - atherosclerosis
Skin – decreased turgor, wrinkling
Mucous membranes - dryness
Loss of libido – decrease testostone, atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

History (cont.)

A

Menstrual history
contraceptive history
obstetrical history
gynecologic history
sexual history
life event changes
lifestyle
medical history
alternative medical treatments
beliefs about menopause and expectations
(Emphasize the importance of contraception until 1 year after last menses
Gyn: surgery, pap smear, mammo or breast issues, SSBE, incontinence
sex: unresponsive recent changes
life event: resumption or retirement of career, empty nest, children in or out of home, grandchildren, hobbies
lifestyles: exercise, diet, smoking, etoh, drugs stressors
medical? Chronic disease, medications OTC
alternative : herbs, acupuncture homeopathic

*** anticipate needs of patient!!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Physical Exam

A

VS
Thyroid
Cardiac and respiratory
Abdominal
Full gyn exam
Rectal
fecal occult blood
(General exam look for thinning hair and skin
Abdomen metabolic syndrome common after menopause central obesity > 35 waist
atrophy of the vagina and vulva, loss of pubic hair,
cystocele, rectocele, urethrocele)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Laboratory tests

A
Cultures if necessary
pap smear
mammogram 
fecal occult blood
TSH if not done recently
CBC if bleeding heavy (menorrhagia)
pregnancy test if history indicates
FSH > 40
Estradiol <35
BMD
Lipid profile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Differential

A
Carcinoma of genital tract
Pregnancy
Endocrine Disease
Decrease nutritional state, obesity
Increase exercise pattern
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hormone Replacement therapy

A

HRT is combined estrogen/progesterone therapy that MUST be used in a woman with an intact uterus
Cyclic or continuous treatment
ERT is estrogen only replacement therapy and is used with a woman that has undergone a hysterectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Benefits of HRT

A
Decrease vasomotor symptoms
Improvement in QOL
Improvement in urogenital symptoms
Decrease osteoporosis risk
Decrease cardiovascular disease
May protect against dementia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HRT Indications – patient selection

A

To relieve uncontrolled vasomotor symptoms
To improve urogenital symptoms (LT therapy is required)
To prevent osteoporosis
For women with early menopause until the age of natural menopause (51yrs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HRT Contraindications

A

Undiagnosed vaginal bleeding
Known or suspected pregnancy
Vascular thromboembolic episodes (CVA,MI, DVT, Thrombophlebitis)
Active liver disease acute or chronic
Known or suspected cancer of the breast or reproductive tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
HRT Precautions
``` Type I DM active gallbladder disease > 1ppd smoker obesity FMH breast Cancer Fibroid uterus hx of peripheral vascular episode migraines elevated triglycerides ```
26
HRT Candidate
Newly menopausal (within 5 years) Good health No risk factors for heart disease or breast CA (no first degree relative and neg fmx for BRCA1 or 2) Non smoker, Non-obese Normal Blood sugar and blood pressure Moderate to severe vasomotor s/s or menopausal s/s (Relief of Hot flashes/flushes, irritability, mood changes, sleep disturbances ? Can you function in your day to day activities. Relief of atrophy, vaginal dryness, dysparunia)
27
HRT Risks
Blood Clots Gall Bladder Disease Breast Cancer < 4yr no increase risk 4-10 years questionable > 10 year increase risk Increased cardiac events in 1st year use with patient with prior heart disease – HERS II (Goal of therapy, less than 5 years use, that’s what we tell patients Instability of blood vessels)
28
Women’s Health Initiatives
``` E2/Progesterone arm halted after 5.2 years 8 More will develop breast cancer >4yrs 7 more will have heart attack 8 more will have stroke 8 more will have blood clot in lungs 3yr 5 fewer will have hip fractures overall harm outweighs the benefits ```
29
Women’s Health Initiatives (notes)
15 year study looked at the common cause of death, disability and impaired QOL in PM women – had 3 arms ert, ert/prog, nothing The Women’s Health Initiative (WHI) study in 2002 showed that oral horse estrogens and progestins (Prempro) increased the risk of breast and ovarian cancer and heart disease and strokes. Many experts feel the study design was flawed because they used older women (average age 62) some of whom had been on no HRT for 20 years so they were more likely to already have disease.  Furthermore, many of these risks may be from the use of oral estrogen. Another possible explanation for the risks in WHI may arise from using synthetic hormones instead of the natural hormones.  Premarin comes from horse estrogen and the synthetic progestin, medroxyprogesterone (Provera) is substituted for progesterone. WHI utilized a specific product, Prempro, that combines Premarin and Provera in one pill that’s taken daily. So the adverse effects could be caused from the use of oral estrogens,  synthetic hormones or from the unique combination of two synthetic hormones.
30
Recommendations from ACOG
Cardiac protection-counsel on other methods Osteoporosis prevention- ok, but other alternatives available Short term use for Vasomotor S/S 1-4 years Long term use for Vasomotor S/S-creams, mood elevators, sleeping pills Estrogen with Progesterone 5 years use ok Estrogen alone can be used up to 7 years (Cardiac – diet, exercise, cholesterol lower meds, Ca, vit D, vasomotor)
31
ERT – estrogen replacement therapy
``` Conjugated estrogen – Premarin (0.3/0.45/0.625,0.9,1.25mg/d) Esterified estrogen – Menest (0.3/0.625,1.25,2.5mg/d) Transdermal estrogen – Vivelle dot-, never on the breast tissues, Vivelle, Estraderm, Alora, Climara, Esclim, Menostar, FemPatch **avoids liver effects and less effect on triglycerides and lipids compared to oral formulations. Micronized estrogen – Estradiol 1.0mg/d ```
32
HRT – Combining progesterone
*****MUST be used in ALL patients intact uterus Provera or Prometrium Cyclic – taken the first 10-15 days of the month with estrogen Continuous – taken everyday that estrogen is taken, usually 2.5-5.0 mg qd of MPA Combined products – Prempro, Premphase, FemHRT, Activella, Ortho-Prefest, CombiPatch
33
HRT – Combining progesterone (notes)
Cyclic will bring on menses Continuous no menses, may have btb for up to 6 months on products, is still btb can increase progesterone – ex, if start on 2.5 prempro then increase to 5.0 prempro Prometrium – natural progesterone, peanut oil based, check allergies to peanuts 100-200mg/day Discuss if you haven’t how estrogen works on the uterus and how progesterone counteracts that.
34
Side Effects to Hormone Therapy
BTB or withdrawal bleeding Progesterone: breast tenderness, fluid retention, wgt gain, depression, irritability increase fibroids allergic reaction to patch Virilization with testosterone products (If BTB on cyclic progesterone increase progesterone dose)
35
Education
``` Proper way to take meds Report bleeding SBE exercise and calcium 1000 mg/qd Preventative health measure (pap,mammo,fobt, colonoscopy) S/S of danger signs (CVA, MI, Endo CA) ```
36
Alternatives - Sleep
``` Improve sleep habits Melatonin Gabapentin - 300mg 1-2 hours before bedtime, some patients may need 600mg Lunesta - 2mg qhs Ambien - 5mg qhs (no longer 10mg) ```
37
Alternatives - Sleep (notes)
Sleep Hygiene-cool temperature room, avoid naps, exercise, no etoh or caffeine, regular sleep wake cycle, dark and quiet, limit beverage no tob SE of gabapentin- drowsiness, dizziness, spacy feeling usually goes away after about 1 month should be taken before bed half life 5-7 hours Eszopiclone-Lunesta can use long term SE Drowsiness and impairment even in am so use lowest dose Zolpidem-Ambien least expenseive also comes in ER ER approved for long term SE same as above recommended dose lowered high blood levels in the morning and impaired activities
38
Alternatives – Vasomotor s/s
Venlafexine- venlafaxine ER 37.5 qd x 1 week then 75mg once a day or Immediate release 37.5mg qd x 1 week then 37.5 mg bid Gabapentin- 600mg q hs or 300mg TID depending on when the flashes take place (Hot flashes or night sweats) Clonidine – 50-75 mcg/day SSRI some effect+/- Paroxetine 25mg qd Fluoxetine 20mg qd Sertraline 50mg qd (Effexor: SNRI reduced HF 33% Neurontin: Reduced HF 35-38% but varying doses from 900mg to 2500mg SSRI: paxil, prozac, zoloft) Effexor- (Gabapentin- hot flashes, night sweats SSRI best to manage hot flashes, low dose, usually no SE, if already on it, increase up to 40, follow up, 3 mos follow up, check to make sure if doing ok)
39
Complimentary approaches
May be effective - Estroven, Black Cohash, Soy, Vitamin E | No evidence – Dong quai, acupuncture, yoga, Evening primrose, Ginseng, Kava, Red Clover, Flaxseed
40
Complimentary approaches (notes)
(Soy: Asian-menopausal symptom relief but contain phyto-estrogen Isoflavones which is under investigation for cancer risk. Dietary soy binds more readily to estrogen receptors in the body and safety with use in women with estrogen dependent tumor is unclear. Red Clover: 40mg not enough 80mg reduced hot flashes, side effect:breast tenderness, wgt gain, menstrual changes. Increases endometrial lining with use with soy (1 study) Black Cohosh: reduces hot flashes with very little know side effects or adverse events. No long term studies. May alter the serotonin level as MOA. Hops: Estrogenic Flavonoids. Risk of unopposed estrogen and cancer. Evening primrose: Only one study, with no effect on hot flashes when compared with placebo. Increased N/D and H/A. drug interactions-anti-inflammatory drugs, siezure meds, Beta blockers, corticosteriods, anti coagulants and antipsychotics. Dong Quai: No study to prove benefit but photosensitivity and excessive bleeding with anticoagulants. Ginseng: estrogenic properties. Side effects: insomnia, diarrhea, vaginal bleeding, mastaglia, increase labido. Caution with HTN, DM or Caffeine intake. Flaxseed: estrogenic, antiestrogenic, steriod like activities.may delay absorption of other drugs that are taken simultaneously. No SE.)
41
Vulvo-vaginal Atrophy (VVA)
85 million women > 50 years of age in 2014 10-40% experience VVA=16 million women/600,000 new cases each year Women on aromatase inhibitors 2 x as likely to develop VVA Only 25% seek help FDA Local Vaginal Preparation is recommended
42
ERT
Vaginal Creams or suppository Premarin cream 0.625, Ogen1-2 appl QD for 2 weeks then 2 x week Estrace 2-4 grQd x 2w, 1-2 gr qd x2w, then 1 gr 1-3 x week *****Estring vaginal ring continuous release for 90 days, needs replacement q 90 days *******Caplet Vagifem 10ug qd x 2wk then 2 x week Osphena – 60mg QD – estrogen receptor modulator
43
Treatment of VVA when ERT is contraindicated – hx of Br ca, Gyn ca
``` OTC lubricants – Ky Jelly, Astroglide OTC vaginal moisturizers – Lubrin, KY longlasting, Replens Vaseline, Aquaphor, Vit E oil – externally Mild soaps (Dove unscented bar soap), warm soaks with baking soda ```
44
``` For the menopausal woman who has a contraindication to estrogen use, a potential alternative treatment for hot flashes that is considered to be safe and effective is: A. Lisinopril B. Fluoxetine C. Methyldopa D. Raloxifene ```
B. Fluoxetine
45
A 50-yr old healthy, nonsmoking woman on low-dose oral contraceptives asks how she will know when she has reached menopause and does not have to worry about getting pregnant. An appropriate response would be: A. She can stay on COC indefinitely as they provide the same hormone dose as menopausal HT. B. She can discontinue COC now and switch to HRT without worrying about pregnancy. C. She can continue COC until age 55 and then switch to HT if needed. D. She should discontinue COC for 3 months and then have a test for FSH level.
C
46
A 65-yr old woman currently on cyclic HT presents for routine annual exam. She states she has been healthy in the last year and she is having no problems with her HT. On bimanual examination, a 4-cm nontender ovary is palpated. Appropriate management for this woman would include: A. Order a pelvic US and refer for further evaluation B. Discontinue HT and repeat the bimanual exam in 2 months C. Change to a continuous HT regimen and recheck in 2 months D. Have her return in 1 year as this is a normal finding for a 65-yr old
A. ovaries usually 2-3 cm- evaluate, ultrasound
47
Osteoporosis
Porous bone characterized by low bone mass and deterioration of bone tissue, which leads to increase risk for fracture Effects 52 millions Americans, 80% women 1:2 women and 1:4 men over 50 will have a osteoporosis fracture in their life time Responsible for 2 million fractures/year Costs: 19 billion/year *****In the 5-7 yrs following menopause, a woman can lose up to 20% of her bone density.
48
Osteoporosis Risk Factors
- history of fracture, advanced age >50, low E2, women, caucasian, FMH, Wgt< 127 lbs - Secondary r/t meds or medical conditions - Glucocorticoids, thyroid Rx, anticonvulsants, cigarettes, excessive ETOH - 1/3 will enter LTC within 1year of fracture - Vertebral FX-Increase mortality, LT pain,
49
Putting it into Perspective
A woman’s risk of breaking a hip due to osteoporosis is equal to her risk of breast, ovarian and uterine cancer combined. And a man age 50 or older is more likely to break a bone due to osteoporosis than he is to get prostate cancer. (Educate both men and women about the risk and give teaching about healthy diet)
50
Bone Mineral Density
``` Should be done on patients at risk >65yo Family history small frame smoker, ETOH, gluccocorticoid use post-menopausal women not on HRT Low activity early menopause Hx of rib, hip, forearm, or vertebral fracture ```
51
Osteoporosis screening
USPSTF – Aged 65 and older should be screened routinely, or at age 60 if increased risk for osteoporotic fracture Repeat study based on results and treatment *****DEXA screening – dual energy x-ray absorptiometry is the most widely used. It is quick and rx exposure is one tenth of standard chest x-ray. Measures hip, spine, wrist
52
BMD******* | T scores
Normal – BMD within 1 SD of a young normal adult; Tscore – above -1.0 (research retest 10-15 yrs) Osteopenia – BMD between 1 and 2.5 sd below that of a young normal adult; Tscore -1.0 to -2.5= retest 2-5yr Osteoporosis – BMD between 2.5 sd or more that of a young normal adult; T-score at or below -2.5=retest 1yr after RX If osteopenic or normal with risk factors use preventative treatment If osteoporotic use treatment regimens If results show osteopenia/ostoeporosis a FRAX test may be ordered. This test uses BMD results and additional info to predict risk of breaking a bone in 10 yrs.
53
Treatment
Calcium Requirement Women on HRT 1000mg Calcium with 400-800 Vitamin D No HRT 1500 mg Calcium with 400-800 Vitamin D Men 1000 mg of calcium with 400-800 vitamin D Over 65 -1500mg Calcium and 400-800 Vitamin D, both men and women with or without HRT
54
Treatment-Alendronate (Biophosphonate)
Treatment and prevention of osteoporosis in postmenopausal women increases bone mass and prevents hip, wrist and spine fractures 50% ****P: Fosamax 5 mg QD; 35 mg Qweek ****T: Fosamax 10mg QD; 70mg qweek ****Strict dosing regimen – empty stomach, Water, upright for 30 minutes Contraindicated: Hypocalc,esophageal disease, inability to follow dosing rules (Long term use > 5 years may have an increase in atypical subtrochantic fracture (femur shaft) 13% of occuring vs. 24 % of typical trachanter neck fracture. Benefits still outweight the risk. If stop biphosphonate after 5years, will only prevent 1 atypical subtrachanter fx. FDA on going. Jaw- proper dental care needed) (FIRST THING IN THE MORNING, DO NOT LAY DOWN FOR 30 MIN, ONCE A WEEK DOSE MORE TOLERABLE BONIVA- NEEDS UPRIGHT FOR 60 MIN TO PREVENT STOMACH UPSET)
55
Treatment-Residronate (biophosphonate) | tables
Treatment and Prevention of osteoporosis Suppresses osteoclast activity Actonel 35mg qweek Same dosing rules, contraindications and SE 41% reduction in Vertebral fx and 39% reduction in non-vertebral fxs.
56
Ibandronate (Biphosphonate) | tables
Treatment and prevention of osteoporosis in post menopausal woman Boniva 2.5mg QD or 150mg Q Month Take 60 minutes before first food or drink/or any vitamins/calcium Same dosing instructions as other biphosphonates If missed dose and next > 7 days take missed pill and resume regular schedule. If < 7 days don’t take missed pill, continue on. (Evista- helps to preserve bone mass Estrogen- up to avarage age, not for tx of osteoporosis Calcitonin spray- Tscores in the spine, nasal spray Endocrinology will manage the parathyroid hormone Prevvention, won’t build back, just for prevention of vertebral fractures Cont calcium and Vit D- encourage to continue, exercise is the best thing,)
57
Treatment-Raloxifene (SERM)
Prevention & treatment of osteoporosis in post-menopausal women decreases bone turnover and bone resorption which increase bone density – acts like estrogen Evista 60mg/QD Contraindication: Thromboembolic disease ******SE: Leg cramps and hot flashes****** DVT most risky with in first 4 months and with immobilization -should D/C 72 hours + effect on Chol, no risk breast/uterus
58
Treatment-Calcitonin
Treatment for women greater than 5yrs post-menopausal, decreases vertebral fx36% Inhibits bone resportion, suppresses osteoclast activity Miacalcin Nasal Spray 200IU/day one spray/day alternate nostrils daily contraindication: allergy to med or salmon SE: rhinitis, athralgia, back pain, HA, epitaxis
59
The National Osteoporosis Foundation recommends which of the following for women age 50 and older? A. Ca supplement of 1500 mg in addition to calcium obtained through diet each day B. Lower doses of vitamin D if woman has chronic renal failure C. Total of 800-1000 IU of vitamin D every day D. Total daily calcium intake of 1800mg every day
C Total 800-2000 IU of vitamin D every D for 50 yo and older Secodn questions- do not worry about thromboembolic with biophosphonates
60
Which of the following does not place a woman at increased risk for venous thrombosis? A. Bioidentical estrogen B. Bisphosphonates C. Conjugated estrogen D. Estrogen agonists/antagonists (SERM – Evista).
B | Second questions- do not worry about thromboembolic with bisphosphonates